Form 4 for GLUE Monte Rosa Therapeutics, Inc.
Accepted 2026-05-22 16:05:09 ET · period of report 2026-05-21 · accession 0001193125-26-236840 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-22 16:05 | 2026-05-21 | GLUE | Manning Anthony M. | Dir | M - OptEx | $4.16 | +10.0K | 10.0K | New | +$41.6K |
| D | 2026-05-22 16:05 | 2026-05-21 | GLUE | Manning Anthony M. | Dir | S - Sale+OE | $18.01 | -10.0K | 0 | -100% | -$180.1K |
| D | 2026-05-22 16:05 | 2026-05-21 | GLUE | Manning Anthony M. | Dir | M - OptEx | $0.00 | -10.0K | 12.1K | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-21 | M | A | 10,000 | $4.16 | 10,000 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-21 | S | D | 10,000 | $18.01 | 0 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-05-21 | M | D | 10,000 | $0.00 | 12,100 | D | $4.16 · — to 2034-06-12 | 10,000 Common Stock | (F1) The shares subject to this option are fully vested and exercisable. |